Global Animal Vaccine Adjuvant Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Animal Vaccine Adjuvant Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combinationthese are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Animal Vaccine Adjuvant report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Vaccine Adjuvant market is projected to reach US$ 496.5 million in 2033, increasing from US$ 330 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2033. Demand from Livestock Vaccines and Companion Animals Vaccines are the major drivers for the industry.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Animal Vaccine Adjuvant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Vaccine Adjuvant market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Vaccine Adjuvant introduction, etc. Animal Vaccine Adjuvant Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Animal Vaccine Adjuvant market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Animal Vaccine Adjuvant report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Vaccine Adjuvant market is projected to reach US$ 496.5 million in 2033, increasing from US$ 330 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2033. Demand from Livestock Vaccines and Companion Animals Vaccines are the major drivers for the industry.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Animal Vaccine Adjuvant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Vaccine Adjuvant market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Vaccine Adjuvant introduction, etc. Animal Vaccine Adjuvant Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Animal Vaccine Adjuvant market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.